Stocks of the Hour: Atomo Diagnostics, AdAlta, Aruma Resources
A snapshot of the stocks on the move, featuring Atomo Diagnostics (ASX:AT1), AdAlta (ASX:1AD) and Aruma Resources (ASX:AAJ).
Read More
Atomo’s innovative rapid diagnostic test (RDT) platforms simplify procedures, mitigate common user errors, and enhance test performance. Their unmatched usability has won the respect of frontline healthcare providers worldwide, and has made Atomo the OEM partner of choice for diagnostic companies wanting to enhance their RDT product offerings.
Atomo’s all-in-one RDT platforms put the end user first and make it easy to test and screen for a range of infectious diseases and chronic conditions.
Their unmatched usability has won the respect of frontline healthcare providers worldwide, and has made Atomo the OEM partner of choice for diagnostic manufacturers looking to transform their RDT offerings.
Award-winning Australian innovation
Designed for simplicity
A snapshot of the stocks on the move, featuring Atomo Diagnostics (ASX:AT1), AdAlta (ASX:1AD) and Aruma Resources (ASX:AAJ).
WATCH VIDEOA snapshot of the stocks on the move, featuring Atomo Diagnostics (ASX:AT1), AdAlta (ASX:1AD) and Aruma Resources (ASX:AAJ).
Read More
Will Souter - CFO - Atomo Diagnostics is a global leader in the user-centered design of innovative, accurate and reliable rapid diagnostics.
Read More
John Kelly - Founder, Managing Director & CEO - Atomo Diagnostics Limited is a global leader in the design of medical devices for blood-based rapid testing for professional use and self-testing.
Read More